Cargando…

Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years

Influenza outbreaks caused by A/H7N9 viruses have occurred since 2013. After 2016, A/H7N9 influenza viruses underwent evolutionary changes. In this study, we examined the antigenic properties of influenza neuraminidase (NA) of A/H7N9 viruses as part of a live influenza vaccine (LAIV). It was shown t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desheva, Yulia, Losev, Igor, Petkova, Nadezhda, Kudar, Polina, Donina, Svetlana, Mamontov, Andrey, Tsai, Chih-Hsuan, Chao, Yu-Chan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503534/ https://www.ncbi.nlm.nih.gov/pubmed/36145348 http://dx.doi.org/10.3390/ph15091127

Ejemplares similares

Study of Antibodies to Influenza Neuraminidase N2
por: Desheva, Yulia, et al.
Publicado: (2022)

Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
por: Desheva, Yulia, et al.
Publicado: (2022)

Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis
por: Desheva, Yulia, et al.
Publicado: (2023)

Developing a Live Probiotic Vaccine Based on the Enterococcus faecium L3 Strain Expressing Influenza Neuraminidase
por: Desheva, Yulia, et al.
Publicado: (2021)

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
por: Desheva, Yulia, et al.
Publicado: (2020)

Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
por: Sergeeva, Mariia V., et al.
Publicado: (2023)

Mast cell degranulation and histamine release during A/H5N1 influenza infection in influenza-sensitized mice
por: Desheva, Yulia, et al.
Publicado: (2020)

Study of Antibody-Dependent Reactions of Mast Cells In Vitro and in a Model of Severe Influenza Infection in Mice
por: Mamontov, Andrey, et al.
Publicado: (2021)

Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
por: Desheva, Yulia, et al.
Publicado: (2022)

Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
por: Desheva, Yulia A, et al.
Publicado: (2015)

Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals
por: Desheva, Yulia, et al.
Publicado: (2018)

Pilot Study Results on Antibodies to the S- and N-Proteins of SARS-CoV-2 in Paired Sera from COVID-19 Patients with Varying Severity
por: Desheva, Yulia, et al.
Publicado: (2023)

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials)
por: Rudenko, Larisa, et al.
Publicado: (2008)

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein
por: Rekstin, Andrey, et al.
Publicado: (2017)

Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections
por: Desheva, Yulia, et al.
Publicado: (2019)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine
por: Rudenko, Larisa, et al.
Publicado: (2015)

Identification of key residues involved in the neuraminidase antigenic variation of H9N2 influenza virus
por: Wang, Fei, et al.
Publicado: (2021)

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models
por: Rekstin, Andrey, et al.
Publicado: (2014)

Role of Neuraminidase in Influenza A(H7N9) Virus Receptor Binding
por: Benton, Donald J., et al.
Publicado: (2017)

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019)

Influenza Virus Neuraminidase: Structure and Function
por: Shtyrya, Y.A., et al.
Publicado: (2009)

Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
por: Gamblin, Steven J., et al.
Publicado: (2010)

Influenza Virus Neuraminidase Structure and Functions
por: McAuley, Julie L., et al.
Publicado: (2019)

Replication of H9 influenza viruses in the human ex vivo respiratory tract, and the influence of neuraminidase on virus release
por: Chan, Renee W. Y., et al.
Publicado: (2017)

Bacterial Neuraminidase Rescues Influenza Virus Replication from Inhibition by a Neuraminidase Inhibitor
por: Nishikawa, Tomoko, et al.
Publicado: (2012)

Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection
por: Xiong, Fei-Fei, et al.
Publicado: (2020)

Influenza A Virus Hemagglutinin Antibody Escape Promotes Neuraminidase Antigenic Variation and Drug Resistance
por: Hensley, Scott E., et al.
Publicado: (2011)

A miniaturized assay for influenza neuraminidase‐inhibiting antibodies utilizing reverse genetics‐derived antigens
por: Sandbulte, Matthew R., et al.
Publicado: (2009)

Antigenic evolution of human influenza H3N2 neuraminidase is constrained by charge balancing
por: Wang, Yiquan, et al.
Publicado: (2021)

Mechanism of 150-cavity formation in influenza neuraminidase
por: Amaro, Rommie E., et al.
Publicado: (2011)

Systematic review of influenza resistance to the neuraminidase inhibitors
por: Thorlund, Kristian, et al.
Publicado: (2011)

The role of neuraminidase inhibitors in the treatment and prevention of influenza
por: Naem, Shahrour
Publicado: (2001)

Exploring the chemical space of influenza neuraminidase inhibitors
por: Anuwongcharoen, Nuttapat, et al.
Publicado: (2016)

Aurintricarboxylic acid inhibits influenza virus neuraminidase
por: Hung, Hui-Chen, et al.
Publicado: (2009)

Inherent Serum Inhibition of Influenza Virus Neuraminidases
por: Skarlupka, Amanda L., et al.
Publicado: (2021)

Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses
por: Wu, Yan, et al.
Publicado: (2013)

Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides
por: Desheva, Yulia A, et al.
Publicado: (2017)

In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen
por: Wohlbold, Teddy John, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e9kj9qmplfcud396i99j9fcomo